Purple Biotech News

Purple Biotech Analyst Ratings

BenzingaNov 15, 2024 14:44 ET

Purple Biotech Analyst Ratings

BenzingaSep 20, 2024 13:34 ET

H.C. Wainwright Maintains Purple Biotech(PPBT.US) With Buy Rating, Cuts Target Price to $33

Moomoo NewsSep 19, 2024 06:31 ET

HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $8

BenzingaSep 19, 2024 06:29 ET

Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS)

TipRanksAug 20, 2024 04:12 ET

Purple Biotech Analyst Ratings

BenzingaAug 19, 2024 07:44 ET

Purple Biotech Analyst Ratings

BenzingaJul 11, 2024 13:24 ET

Promising Phase 2 Results for Purple Biotech's CM24 in Pancreatic Cancer Treatment Bolster Buy Rating

TipRanksJul 11, 2024 12:20 ET

Buy Rating Justified by Purple Biotech's Promising Clinical Data and Market Potential

TipRanksMay 21, 2024 11:50 ET

Purple Biotech Analyst Ratings

BenzingaMay 21, 2024 11:37 ET

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

BenzingaMay 21, 2024 11:36 ET

Purple Biotech Analyst Ratings

BenzingaApr 26, 2024 14:26 ET

Purple Biotech Analyst Ratings

BenzingaMar 7, 2024 13:57 ET

Purple Biotech Analyst Ratings

BenzingaMar 5, 2024 12:10 ET

Promising Pipeline Prospects for Purple Biotech: Buy Rating Affirmed Amidst Anticipated Clinical Advancements

TipRanksMar 5, 2024 11:41 ET

Purple Biotech Analyst Ratings

BenzingaFeb 27, 2024 12:44 ET

Buy Rating Justified by Promising Phase 1 Results of Purple Biotech's NT219 in SCCHN Treatment

TipRanksFeb 27, 2024 12:25 ET

Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Sanofi (OtherSNYNF)

TipRanksFeb 1, 2024 10:40 ET

Purple Biotech Analyst Ratings

BenzingaNov 21, 2023 13:44 ET

Promising Clinical Trial Results and Accelerated Enrollment Boost Purple Biotech's Buy Rating

TipRanksNov 21, 2023 11:35 ET